Our goal is to develop better treatment interventions and ultimately prevent and cure AD. Our basic and translational scientists are committed to identifying the causes of Alzheimer’s disease but more importantly the emphasis is now on preventing memory loss. In order for scientists to know what works best they must test new therapies. This requires volunteers like you to participate in research.
Clinical trials at Emory must follow strict rules that are set by the Institutional Review Board (IRB). This group of people review research to make sure it will be done safely and that the benefits of the research outweigh the risks to the participants. This is done to protect the study participants welfare, health, safety and privacy while they are involved in a clinical trial. Some clinical trials may be conducted to examine alternative indications for existing medications or treatments.
These trials can take place in hospitals, doctor’s offices, universities or private research clinics. Whatever your area of research interest may be, we all have the same goal: to end Alzheimer’s.